BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33194318)

  • 1. Usefulness and robustness of Immunoscore for personalized management of cancer patients.
    Marliot F; Pagès F; Galon J
    Oncoimmunology; 2020 Oct; 9(1):1832324. PubMed ID: 33194318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The consensus immunoscore: toward a new classification of colorectal cancer.
    Lanzi A; Pagès F; Lagorce-Pagès C; Galon J
    Oncoimmunology; 2020 Jul; 9(1):1789032. PubMed ID: 32934885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No time to die: the consensus immunoscore for predicting survival and response to chemotherapy of locally advanced colon cancer patients in a multicenter international study.
    Ascierto PA; Marincola FM; Fox BA; Galon J
    Oncoimmunology; 2020 Oct; 9(1):1826132. PubMed ID: 33194317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precision immunity: Immunoscore and neoadjuvant treatment in bladder cancer.
    Nassif EF; Thibault C; Oudard S; Galon J
    Oncoimmunology; 2021 Feb; 10(1):1888488. PubMed ID: 33659099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The consensus Immunoscore in phase 3 clinical trials; potential impact on patient management decisions.
    Pagès F; Taieb J; Laurent-Puig P; Galon J
    Oncoimmunology; 2020 Aug; 9(1):1812221. PubMed ID: 32939329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The consensus Immunoscore in phase 3 clinical trial (N0147) and impact on patient management decisions.
    Lanzi A; Sinicrope FA; Benson AB; Galon J
    Oncoimmunology; 2020 Jul; 9(1):1796003. PubMed ID: 32934890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study.
    Pagès F; Mlecnik B; Marliot F; Bindea G; Ou FS; Bifulco C; Lugli A; Zlobec I; Rau TT; Berger MD; Nagtegaal ID; Vink-Börger E; Hartmann A; Geppert C; Kolwelter J; Merkel S; Grützmann R; Van den Eynde M; Jouret-Mourin A; Kartheuser A; Léonard D; Remue C; Wang JY; Bavi P; Roehrl MHA; Ohashi PS; Nguyen LT; Han S; MacGregor HL; Hafezi-Bakhtiari S; Wouters BG; Masucci GV; Andersson EK; Zavadova E; Vocka M; Spacek J; Petruzelka L; Konopasek B; Dundr P; Skalova H; Nemejcova K; Botti G; Tatangelo F; Delrio P; Ciliberto G; Maio M; Laghi L; Grizzi F; Fredriksen T; Buttard B; Angelova M; Vasaturo A; Maby P; Church SE; Angell HK; Lafontaine L; Bruni D; El Sissy C; Haicheur N; Kirilovsky A; Berger A; Lagorce C; Meyers JP; Paustian C; Feng Z; Ballesteros-Merino C; Dijkstra J; van de Water C; van Lent-van Vliet S; Knijn N; Mușină AM; Scripcariu DV; Popivanova B; Xu M; Fujita T; Hazama S; Suzuki N; Nagano H; Okuno K; Torigoe T; Sato N; Furuhata T; Takemasa I; Itoh K; Patel PS; Vora HH; Shah B; Patel JB; Rajvik KN; Pandya SJ; Shukla SN; Wang Y; Zhang G; Kawakami Y; Marincola FM; Ascierto PA; Sargent DJ; Fox BA; Galon J
    Lancet; 2018 May; 391(10135):2128-2139. PubMed ID: 29754777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunity to live: an immunopathoscore using the consensus Immunoscore to best define the risk of recurrence and death in stage IV metastatic patients.
    Baldin P; Van den Eynde M; Mlecnik B; Galon J
    Oncoimmunology; 2020 Oct; 9(1):1826133. PubMed ID: 33110705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification of early-stage colon cancer with Immunoscore
    Yalcin S; Philip PA; Athanasiadis I; Bazarbashi S; Shamseddine A
    Future Oncol; 2022 Feb; 18(5):613-623. PubMed ID: 34904905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoscore
    Blair HA
    Mol Diagn Ther; 2020 Jun; 24(3):365-370. PubMed ID: 32232741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoscore and its introduction in clinical practice.
    Galon J; Lanzi A
    Q J Nucl Med Mol Imaging; 2020 Jun; 64(2):152-161. PubMed ID: 32107902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational bases for the use of the Immunoscore in routine clinical settings as a prognostic and predictive biomarker in cancer patients.
    Kirilovsky A; Marliot F; El Sissy C; Haicheur N; Galon J; Pagès F
    Int Immunol; 2016 Aug; 28(8):373-82. PubMed ID: 27121213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Immunoscore in the Clinical Practice of Patients with Colon and Rectal Cancers.
    Zeitoun G; Sissy CE; Kirilovsky A; Anitei G; Todosi AM; Marliot F; Haicheur N; Lagorce C; Berger A; Zinzindohoué F; Galon J; Scripcariu V; Pagès F
    Chirurgia (Bucur); 2019; 114(2):152-161. PubMed ID: 31060646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards the introduction of the 'Immunoscore' in the classification of malignant tumours.
    Galon J; Mlecnik B; Bindea G; Angell HK; Berger A; Lagorce C; Lugli A; Zlobec I; Hartmann A; Bifulco C; Nagtegaal ID; Palmqvist R; Masucci GV; Botti G; Tatangelo F; Delrio P; Maio M; Laghi L; Grizzi F; Asslaber M; D'Arrigo C; Vidal-Vanaclocha F; Zavadova E; Chouchane L; Ohashi PS; Hafezi-Bakhtiari S; Wouters BG; Roehrl M; Nguyen L; Kawakami Y; Hazama S; Okuno K; Ogino S; Gibbs P; Waring P; Sato N; Torigoe T; Itoh K; Patel PS; Shukla SN; Wang Y; Kopetz S; Sinicrope FA; Scripcariu V; Ascierto PA; Marincola FM; Fox BA; Pagès F
    J Pathol; 2014 Jan; 232(2):199-209. PubMed ID: 24122236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Impact of the Immune Microenvironment in Spinal Chordoma: Immunoscore as an Independent Favorable Prognostic Factor.
    Zou MX; Lv GH; Wang XB; Huang W; Li J; Jiang Y; She XL
    Neurosurgery; 2019 Jun; 84(6):E318-E333. PubMed ID: 30032257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoscore assay for the immune classification of solid tumors: Technical aspects, improvements and clinical perspectives.
    Marliot F; Lafontaine L; Galon J
    Methods Enzymol; 2020; 636():109-128. PubMed ID: 32178816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunoscore and Its Predictive Value for Colorectal Cancer].
    Závadová E; Špaček J; Vočka M; Konopásek B; Fučíková T; Netíková I; Dundr P; Skálová H; Petruželka L
    Klin Onkol; 2015; 28 Suppl 4():4S82-5. PubMed ID: 26647895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The correlation of immunoscore and frailty in colorectal cancer.
    Nakao T; Shimada M; Yoshikawa K; Tokunaga T; Nishi M; Kashihara H; Takasu C; Wada Y; Yoshimoto T; Yamashita S; Iwakawa Y
    Int J Clin Oncol; 2022 Mar; 27(3):528-537. PubMed ID: 34846645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Immunoscore system predicts prognosis after liver metastasectomy in colorectal cancer liver metastases.
    Wang Y; Lin HC; Huang MY; Shao Q; Wang ZQ; Wang FH; Yuan YF; Li BK; Wang DS; Ding PR; Chen G; Wu XJ; Lu ZH; Li LR; Pan ZZ; Sun P; Yan SM; Wan DS; Xu RH; Li YH
    Cancer Immunol Immunother; 2018 Mar; 67(3):435-444. PubMed ID: 29204700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiverse of immune microenvironment in metastatic colorectal cancer.
    Van den Eynde M; Mlecnik B; Bindea G; Galon J
    Oncoimmunology; 2020 Sep; 9(1):1824316. PubMed ID: 33457100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.